1,7-phenanthroline has been researched along with Alzheimer Disease in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 12 (60.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drommi, M; Esmieu, C; Hureau, C; Rulmont, C | 1 |
| Anisha, M; Gladis, EHE; Joseph, J; Nagashri, K | 1 |
| Bulova, P; Christian, BT; Devenny, D; Handen, BL; Hardison, R; Hartley, SL; Johnson, SC; Klunk, WE; Lao, PJ; Mihaila, I | 1 |
| Abe, T; Ataka, S; Hasegawa, I; Itoh, Y; Kawabe, J; Kikukawa, T; Mino, T; Saito, H; Takeuchi, J; Wada, Y; Watanabe, Y | 1 |
| Basha, HM; Boopathy, R; Chitra, L; Kumar, CR; Ponne, S | 1 |
| Fan, Q; Lang, M; Wang, L; Wang, W; Wang, X; Xiao, G; Zheng, Y; Zhong, Y; Zhou, B | 1 |
| Barnham, KJ; Caine, JM; Chandana Epa, V; Churches, QI; James, SA; Kenche, VB; Streltsov, VA | 1 |
| Bhat, SS; Jani, V; Joshi, B; Joshi, RR; Kulkarni, PP; Kumbhar, AS; Ramteke, SN; Sonawane, UB; Vyas, NA | 1 |
| Corby, P; Craig, RG; de Leon, MJ; Glodzik, L; Kamer, AR; Linker, R; McHugh, P; Mosconi, L; Pirraglia, E; Rusinek, H; Saxena, D; Shi, C; Svetcov, S; Tsui, W; Vallabhajosula, S; Williams, S; Yi, L | 1 |
| Bottelbergs, A; Kelley, JB; Langlois, X; Schmidt, ME; Staelens, S; Stroobants, S; Waldron, AM; Wintmolders, C | 1 |
| Arcisio-Miranda, M; Cali, MP; Carlos, RM; Carlos-Lima, E; Ito, AS; Pazin, WM; Salles Trevisan, MT; Silva, DE; Venâncio, T | 1 |
| Raymick, J; Schmued, L | 1 |
| Ishii, K | 1 |
| Huang, F; Jia, L; Jiang, T; Li, L; Liu, Y; Ma, G; Pu, X | 1 |
| Barnham, KJ; Bush, AI; Cherny, RA; Masters, CL; Yao, S | 1 |
| Boldron, C; Deraeve, C; Gornitzka, H; Meunier, B; Pitié, M; Van der Auwera, I; Van Leuven, F; Wera, S | 1 |
| Barnham, KJ; Caragounis, A; Cherny, RA; Crouch, PJ; Drew, SC; Du, T; Filiz, G; Hill, AF; Laughton, KM; Li, QX; Masters, CL; Sharples, RA; Volitakis, I; White, AR | 1 |
| Atwood, CS; Beyreuther, K; Bush, AI; Cherny, RA; Fairlie, DP; Huang, X; Legg, JT; Masters, CL; McLean, CA; Tanzi, RE | 1 |
| Barnham, KJ; Beyreuther, K; Bush, AI; Cherny, RA; Li, QX; Lynch, T; Masters, CL; McLean, CA; Multhaup, G; Tanzi, RE; Volitakis, I | 1 |
| Eckman, C; Golde, T; Musunuru, U; Onstead, L; Pinnix, I; Sambamurti, K; Sridharan, A; Tun, H; Ziani-Cherif, C | 1 |
1 review(s) available for 1,7-phenanthroline and Alzheimer Disease
| Article | Year |
|---|---|
[Amyloid PET in Alzheimer research].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Carbon Radioisotopes; Humans; Phenanthrolines; Positron-Emission Tomography; Radiopharmaceuticals; Rhombencephalon; Thiazoles | 2010 |
19 other study(ies) available for 1,7-phenanthroline and Alzheimer Disease
| Article | Year |
|---|---|
Hybrid Bis-Histidine Phenanthroline-Based Ligands to Lessen Aβ-Bound Cu ROS Production: An Illustration of Cu(I) Significance.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Copper; Histidine; Humans; Phenanthrolines; Reactive Oxygen Species | 2021 |
Synthesis, characterisation, DNA binding, acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) activities and molecular docking studies of metal(II) complexes with 1,10-phenanthroline scaffold.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Coordination Complexes; Humans; Metals; Molecular Docking Simulation; Molecular Structure; Phenanthrolines; Structure-Activity Relationship | 2023 |
Cognitive decline and brain amyloid-β accumulation across 3 years in adults with Down syndrome.
Topics: Adult; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Cognition; Cognitive Dysfunction; Down Syndrome; Executive Function; Female; Humans; Male; Memory, Episodic; Middle Aged; Phenanthrolines; Positron-Emission Tomography; Thiazoles; Time Factors | 2017 |
Amyloid deposition and CBF patterns predict conversion of mild cognitive impairment to dementia.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Cognitive Dysfunction; Disease Progression; Female; Follow-Up Studies; Humans; Male; Neuropsychological Tests; Perfusion Imaging; Phenanthrolines; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thiazoles; Tomography, Emission-Computed, Single-Photon | 2018 |
Interaction of metal chelators with different molecular forms of acetylcholinesterase and its significance in Alzheimer's disease treatment.
Topics: Acetylcholinesterase; Alzheimer Disease; Amidohydrolases; Amyloid beta-Peptides; Chelating Agents; Cholinesterase Inhibitors; Esterases; Humans; Hydrophobic and Hydrophilic Interactions; Metals; Molecular Dynamics Simulation; Phenanthrolines | 2013 |
Inhibition of human high-affinity copper importer Ctr1 orthologous in the nervous system of Drosophila ameliorates Aβ42-induced Alzheimer's disease-like symptoms.
Topics: Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Cation Transport Proteins; Cell Count; Chelating Agents; Conditioning, Classical; Copper Transporter 1; Disease Models, Animal; Drosophila; Drosophila Proteins; Gene Expression Regulation; Humans; Locomotion; Longevity; Male; Memory Disorders; Nerve Degeneration; Nervous System; Oxidative Stress; Peptide Fragments; Phenanthrolines; RNA Interference; Time Factors | 2013 |
Structural insights into the interaction of platinum-based inhibitors with the Alzheimer's disease amyloid-β peptide.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Coordination Complexes; Humans; Light; Phenanthrolines; Platinum; Protein Binding; Scattering, Radiation; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2013 |
Ruthenium(II) polypyridyl complex as inhibitor of acetylcholinesterase and Aβ aggregation.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Cholinesterase Inhibitors; Coordination Complexes; Humans; Organometallic Compounds; Phenanthrolines; Pyridines; Ruthenium | 2014 |
Periodontal disease associates with higher brain amyloid load in normal elderly.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Brain; Carbon Radioisotopes; Female; Humans; Male; Middle Aged; Periodontal Diseases; Phenanthrolines; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Thiazoles | 2015 |
In vivo molecular neuroimaging of glucose utilization and its association with fibrillar amyloid-β load in aged APPPS1-21 mice.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Aniline Compounds; Animals; Autoradiography; Brain; Brain Mapping; Carbon Radioisotopes; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Glucose; Humans; Immunohistochemistry; Mice, Inbred C57BL; Mice, Transgenic; Phenanthrolines; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2015 |
Luminescent Ru(II) Phenanthroline Complexes as a Probe for Real-Time Imaging of Aβ Self-Aggregation and Therapeutic Applications in Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Cell Line; Cholinesterase Inhibitors; Electrophorus; Humans; Luminescent Agents; Mice; Optical Imaging; Phenanthrolines; Protein Aggregates; Ruthenium | 2016 |
Introducing Euro-Glo, a rare earth metal chelate with numerous applications for the fluorescent localization of myelin and amyloid plaques in brain tissue sections.
Topics: Alzheimer Disease; Animals; Brain; Chelating Agents; Coordination Complexes; Disease Models, Animal; Fluoresceins; Fluorescent Dyes; Kainic Acid; Mice, Transgenic; Myelin Sheath; Phenanthrolines; Phosphates; Plaque, Amyloid; Rats, Sprague-Dawley; Staining and Labeling | 2017 |
Identification of [PtCl2(phen)] binding modes in amyloid-β peptide and the mechanism of aggregation inhibition.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Binding Sites; Chromatography, High Pressure Liquid; Copper; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Organoplatinum Compounds; Phenanthrolines; Platinum; Protein Binding; Protein Structure, Secondary; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2011 |
Characterizing bathocuproine self-association and subsequent binding to Alzheimer's disease amyloid beta-peptide by NMR.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Humans; Hydrogen; Kinetics; Magnetic Resonance Spectroscopy; Peptide Fragments; Phenanthrolines | 2004 |
Preparation of cyclo-phen-type ligands: chelators of metal ions as potential therapeutic agents in the treatment of neurodegenerative diseases.
Topics: Alzheimer Disease; Animals; Chelating Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Ions; Ligands; Macrocyclic Compounds; Metals; Mice; Mice, Transgenic; Molecular Structure; Neurodegenerative Diseases; Phenanthrolines; Plaque, Amyloid | 2005 |
Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Biological Transport, Active; CHO Cells; Copper; Cricetinae; Cricetulus; Humans; Ligands; Oxyquinoline; Peptides; Phenanthrolines; Zinc | 2007 |
Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Chelating Agents; Copper; Egtazic Acid; Ethylenediamines; Humans; Phenanthrolines; Water; Zinc | 1999 |
Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Chelating Agents; Copper; Humans; Mice; Mice, Transgenic; Nuclear Magnetic Resonance, Biomolecular; Penicillamine; Peptides; Phenanthrolines; Pilot Projects; Solubility; Trientine; Zinc | 2000 |
A novel gamma -secretase assay based on detection of the putative C-terminal fragment-gamma of amyloid beta protein precursor.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Brain; Caspase 3; Caspases; Cells, Cultured; Detergents; Endopeptidases; Guinea Pigs; Hydrogen-Ion Concentration; Membrane Proteins; Molecular Weight; Pepstatins; Peptide Fragments; Phenanthrolines; Protease Inhibitors; Protein Processing, Post-Translational; Solubility; Subcellular Fractions | 2001 |